Asia-Pacific Digital Therapeutic (DTx) Market, By Product and Service Type (Hardware Products, Solutions/Software, and Service), Application (Treatment/ Care-Related Applications, and Preventive Applications), Purchase Mode (Group Purchase Organization and Individual), Sales Channel (B2B and B2C) – Industry Trends and Forecast to 2031.
Asia-Pacific Digital Therapeutic (DTx) Market Analysis and Size
Digital therapeutic (DTx) market is witnessing remarkable growth driven by advancements in technology. The latest methods integrate AI, virtual reality, and personalized algorithms to enhance treatment efficacy. Utilizing these innovations, DTx solutions cater to a broader spectrum of ailments, from mental health to chronic diseases. This progressive landscape signifies a transformative era in healthcare, promising improved patient outcomes and accessibility.
The Asia-Pacific digital therapeutic (DTx) market size was valued at USD 3.78 billion in 2023, is projected to reach USD 20.32 billion by 2031, with a CAGR of 23.4% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product and Service Type (Hardware Products, Solutions/Software, and Service), Application (Treatment/ Care-Related Applications, and Preventive Applications), Purchase Mode (Group Purchase Organization and Individual), Sales Channel (B2B and B2C)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
Omada Health Inc. (U.S.), Welldoc, Inc. (U.S.), 2Morrow, Inc. (U.S.), Teladoc Health, Inc. (U.S.), Propeller HealtH (U.S.), Fitbit LLC (U.S.), Canary Health (U.S.), Noom, Inc. (U.S.), Pear Therapeutics, Inc. (U.S.), Akili Interactive Labs, Inc. (U.S.), Hygieia (U.S.), DarioHealth Corp. (Israel), BigHealth (U.K.), GAIA AG (Germany), Limbix Health, Inc. (U.S.), and Mango Health (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Digital therapeutics (DTx) are software-based interventions designed to treat, manage, or prevent medical conditions. They often employ cognitive behavioral therapy, mindfulness techniques, or other evidence-based approaches to deliver therapeutic benefits. DTx can be accessed via smartphones, tablets, or computers, offering convenient and scalable solutions for individuals seeking to improve their health and well-being.
Asia-Pacific Digital Therapeutic (DTx) Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The surge in chronic diseases such as diabetes, cardiovascular conditions, and mental health disorders is fueling demand for convenient and efficient digital therapeutic solutions. For instance, diabetes affects millions globally, prompting the development of mobile apps such as Livongo, which offer personalized coaching and monitoring, revolutionizing disease management. This increasing prevalence underscores the urgent need for accessible digital therapies, propelling growth in the digital therapeutic market.
- Growing Regulatory Support and Validation
Regulatory agencies such as the FDA in the US and the EMA in Europe are crucial drivers of the digital therapeutic (DTx) market. Their recognition and establishment of pathways for DTx validation and approval foster innovation and market growth. For instance, the FDA's clearance of Pear Therapeutics' reSET, the first prescription digital therapeutic for substance use disorder, underscored regulatory support, instilling confidence in investors and accelerating market adoption.
Opportunities
- Growing Focus on Preventive Healthcare
The emphasis on preventive healthcare drives the digital therapeutic (DTx) market by leveraging behavior modification, lifestyle management, and risk reduction. For instance, DTx platforms such as Omada Health offer personalized programs targeting obesity and related conditions through dietary changes and exercise regimens. By addressing underlying risk factors early, these solutions help prevent the onset or progression of chronic diseases, driving demand for DTx interventions.
- Rising Remote Monitoring and Telehealth
The COVID-19 pandemic catalyzed the widespread adoption of remote monitoring and telehealth solutions, fueling the growth of the digital therapeutic market. Healthcare providers swiftly embraced these technologies to deliver continuous care beyond traditional settings. For instance, companies such as Teladoc Health experienced a surge in demand for their telehealth services, demonstrating the pivotal role of remote monitoring in expanding access to healthcare and driving the uptake of digital therapeutics.
Restraints/Challenges
- Data Privacy and Security Concerns
Data privacy and security concerns surrounding the collection and transmission of sensitive health data can undermine trust in digital therapeutic (DTx) solutions, acting as a significant barrier to market growth. Breaches or perceived vulnerabilities in safeguarding patient information may deter both healthcare providers and patients from adopting DTx interventions.
- Lack of Standardization
The absence of standardized protocols and guidelines for DTx development, deployment, and evaluation creates interoperability issues, quality assurance challenges, and comparability difficulties. This lack of uniformity hampers market growth by impeding seamless integration, ensuring consistent quality, and facilitating meaningful comparison between different digital therapeutic products.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In October 2023, Better Therapeutics, Inc. unveiled AspyreRx, a diabetes digital therapeutic platform tailored to enhance diabetes management. AspyreRx offers personalized experiences empowering patients in effectively managing their condition
- In August 2023, Welldoc, Inc. attained its 10th FDA approval for BlueStar, its diabetes digital health solution, reaffirming its commitment to advancing digital healthcare
- In November 2020, ResMed's randomized controlled trial, published in the Journal of Allergy and Clinical Immunology, showcased significant reductions in inhaler reuse and improved patient compliance with the Propeller Health digital platform, driving increased customer adoption and company valuation
- In April 2020, Smartpatient GmbH initiated a strategic partnership with "Around the Pill" Solutions, aimed at bolstering pharmaceutical development endeavors. This collaboration is poised to yield innovative products, expand customer reach, and augment market value through enhanced product offerings and market presence
Asia-Pacific Digital Therapeutic (DTx) Market Scope
The market is segmented on the basis of product and service type, application, purchase mode and sales channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Service Type
- Hardware Products
- Solutions/Software
- Service
Application
- Treatment/ Care-Related Applications
- Preventive Applications
Purchase Mode
- Group Purchase Organization
- Individual
Sales Channel
- B2B
- B2C
Asia-Pacific Digital Therapeutic (DTx) Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, product and service type, application, purchase mode and sales channel as referenced above.
The countries covered in the market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
Japan is expected to dominate the digital therapeutic (DTx) market in the Asia-Pacific region due to rapid urbanization and rising digital therapeutics companies. As a pioneer in adopting DTx products, Japan leads the way in integrating digital therapeutics into healthcare, reflecting the nation's commitment to innovative healthcare solutions amidst urban development.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Asia-Pacific Digital Therapeutic (DTx) Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Omada Health Inc. (U.S.)
- Welldoc, Inc. (U.S.)
- 2Morrow, Inc. (U.S.)
- Teladoc Health, Inc. (U.S.)
- Propeller HealtH (U.S.)
- Fitbit LLC (U.S.)
- Canary Health (U.S.)
- Noom, Inc. (U.S.)
- Pear Therapeutics, Inc. (U.S.)
- Akili Interactive Labs, Inc. (U.S.)
- Hygieia (U.S.)
- DarioHealth Corp. (Israel)
- BigHealth (U.K.)
- GAIA AG (Germany)
- Limbix Health, Inc. (U.S.)
- Mango Health (U.S.)
SKU-